What are you looking for?
Need help finding what you are looking for? Contact Us

PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1275415

Cover Image

PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1275415

Asia-Pacific (APAC) Medical Devices Industry Outlook 2023

PAGES: 66 Pages
DELIVERY TIME: 1-2 business days
Web Access (Regional License)
USD 4950

Add to Cart

Disruptive Technology Adoption and Transformative Mega Trends Pave the Way for Innovations

While the United States and Europe medical device markets face backlash from the economic slowdown, the Russia-Ukraine war, and the cost-of-living crisis, the APAC medical devices market continues to record phenomenal growth. However, 2023 will be challenging for APAC medtech due to uncertainties arising from the anticipated market slowdown and other macroeconomic factors. Bank failures in the United States also continue to create ripple effects in APAC, with Credit Suisse being the latest.

In this study, Frost & Sullivan analyzes the APAC medical devices market, including macroeconomic factors, the latest trends, revenue forecasts, and predictions. The study period is 2022-2027 and the forecast period is 2023-2027, with 2022 as the base year. We also provide country-specific analyses for China, India, Japan, South Korea, and the rest of APAC. Medical device segments covered include orthopedics, cardiology, respiratory, diabetes, wound care, and others. The study excludes the refurbished medical devices market in APAC.

Our analysis shows that a long-term change that will impact the industry is sustainability. Although lagging in sustainability efforts compared to global counterparts, medtech players in APAC are getting back on track to achieve 2030 Sustainable Development Goals, some even aiming for 2025 or 2027 to achieve carbon neutrality.

The digitalization of medical devices will continue, with original equipment manufacturers digitalizing their devices and operations. This also pushes medtech participants to deliver value for providers and patients with devices and digital data, leading to new business models and disruptive technologies.

As APAC transitions conventional approaches to healthcare innovation, it involves an extensive coalition of healthcare stakeholders. This enables the exploration of new methods that combine diagnostics, devices, digital tools, emerging technologies, and medication to deliver improved patient outcomes.

Frost & Sullivan offers stakeholders insights into opportunities that arise from the increased inclusiveness of underserved patient populations, robotics adoption, and the transition of care from hospitals to home-based models.

Product Code: K88C-54

Table of Contents

Analysis Highlights

  • Market Highlights
  • Global GDP Growth Snapshot
  • Top Predictions for 2023

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top Three Strategic Imperatives on the APAC Medical Devices Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Environment

  • Scope of Analysis
  • Market Segmentation
  • Growth Environment

Macroeconomic Factors

  • Impact Analysis-Supply Chain Disruptions
  • Impact Analysis- Sustainability Initiatives

Revenue Trends, 2022

  • Revenue Forecast by Segment

Top 5 Predictions, 2023

  • Prediction 1
  • Prediction 2
  • Prediction 3
  • Prediction 4
  • Prediction 5

Segment Outlook, 2022

  • Snapshot-Orthopedics
  • Companies to Watch-Orthopedics
  • Snapshot-Cardiology
  • Companies to Watch-Cardiology
  • Snapshot-Respiratory
  • Companies to Watch-Respiratory
  • Snapshot-Diabetes
  • Companies to Watch-Diabetes
  • Snapshot-Wound Care
  • Companies to Watch-Wound Care
  • Snapshot-Others
  • Companies to Watch-Others

Country-specific Analysis, 2023

  • Revenue Forecast by Region
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC

Growth Opportunity Universe

  • Growth Opportunity 1-Robotic Surgery
  • Growth Opportunity 2-Transition of Care to Outside the Hospital
  • Growth Opportunity 3-Screening Solutions for Cervical and Ovarian Cancers


  • Conclusions and Future Outlook

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer
Have a question?

Jeroen Van Heghe

Manager - EMEA



Christine Sirois

Manager - Americas


Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!